Borealis Biosciences gets $150 million Series A financing from Versant Ventures and Novartis AG

VANCOUVER: Borealis Biosciences, a next-generation RNA medicines company, today emerged from stealth with $150 million in combined Series A financing from founding investor Versant Ventures and Novartis AG, as well as committed strategic research collaboration funding from Novartis. Despite recent advances for patients with IgA nephropathy, many other forms of highly prevalent kidney disease remain unaddressed.…

Agronomics’ Onego Bio raises €27 million in Series A financing led by NordicNinja VC

LONDON: Agronomics (LSE: ANIC) portfolio company Onego Bio Ltd has successfully raised €27 million in its Series A financing, led by NordicNinja VC, a Japanese-Nordic VC backing companies in climate and deep tech. In addition, Onego Bio secured a further €9.5 million in non-dilutive funding from Business Finland, a government organisation offering grant funding for…

Agronomics co-leads SuperMeat’s Series A Financing

LONDON, UK: Agronomics Limited has co-led the Series A Financing for portfolio company SuperMeat (The Essence of Meat Ltd) with a US$ 10 million investment, subscribing for 188,158 Series A Preferred Shares, a notice said. SuperMeat is a leading cultivated chicken meat company based in Israel. The funding round was co-led alongside New Agrarian Company…

Allied Minds’ Orbital Sidekick secures $16 million Series A Financing

LONDON: Allied Minds plc announced that its portfolio company, Orbital Sidekick Inc., has conditionally secured $16 million in a Series A Preferred financing round led by Temasek, an investment company headquartered in Singapore. Round participants also include other new investors and existing investors Allied Minds, committing $2.5 million (including conversion of its SAFE), and 11.2…